More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Join PanCAN on Jan. 30, at 11 a.m. PT / 2 p.m. ET, for an educational discussion about pancreatic cancer clinical trials and ...

The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...

On World Pancreatic Cancer Day, hundreds of patients, caregivers and loved ones tuned in for our special virtual event, “How Early Detection Can Change the Course for Pancreatic Cancer.” Our guests ...

While pancreatic cancer remains one of the toughest cancers to treat and is predicted to become the second-leading cause of cancer-related death in the U.S. before 2030, research and treatment ...

Contact a PanCAN Patient Services Case Manager for up-to-date information about pancreatic cancer, clinical trial searches, personalized medicine and support resources. All information and services ...

PanCAN’s Precision Promise Clinical Trial Consortium sites were selected through a competitive, peer-review process and include premier cancer treatment institutions across the country.

Caregivers are crucial in the pancreatic cancer patient’s journey. We have information and resources to guide you as you care for a loved one facing the disease.

Connecting with other survivors, caregivers and loved ones in-person can be a wonderful source of support and encouragement for those dealing with pancreatic cancer. In-person support and networking ...

Clinical trials are research studies that investigate new treatments, new combinations of treatments and new methods of diagnosis as well as surveillance, prevention, and supportive care. Clinical ...